Deep vein thrombosis treatment: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
The primary objectives of treatment of DVT are to control the following: | The primary objectives of treatment of DVT are to control the following: | ||
* Further clot extension. | * Further [[clot]] extension. | ||
* Acute Pulomnary Embolism. | * Acute [[Pulomnary Embolism]]. | ||
* Recurrence of thrombosis. | * Recurrence of [[thrombosis]]. | ||
* Development of late complications (post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension). | * Development of late complications ([[post-thrombotic syndrome]] and chronic thromboembolic [[pulmonary hypertension]]). | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 12:53, 15 December 2011
|
Deep Vein Thrombosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Special Scenario |
|
Trials |
|
Case Studies |
|
Deep vein thrombosis treatment On the Web |
|
Risk calculators and risk factors for Deep vein thrombosis treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2] Ujjwal Rastogi, MBBS [3]
Overview
The primary objectives of treatment of DVT are to control the following:
- Further clot extension.
- Acute Pulomnary Embolism.
- Recurrence of thrombosis.
- Development of late complications (post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension).